FDA Medical devices recall ·
RayStation- Intended as a Radiation Therapy Treatment Planning System Model recall
- Recall number
- Z-1193-2025
- Date
- (initiated January 16, 2025)
- Company / brand
- Raysearch Laboratories Ab
Eugeniavagen 18c, Stockholm, N/A, Sweden - Category
- Medical devices › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 0
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Brand Name: RayStation- Intended as a Radiation Therapy Treatment Planning System Model/Catalog Number: 6.0.0.24 Software Version: RayStation 6
Why was it recalled?
Inconsistency in the use of Density uncertainty in the RayStation functions Robust optimization, Robust evaluation and Compute perturbed dose for proton and light ion treatment plans when a HU-to-mass density CT calibration curve used in RayStation version 4.5 to 2024B including some service packs.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot Code: UDI: 00735000201001320161214 GTIN: 07350002010013 Serial Numbers: 6.0.0.24 Software Revisions: RayStation 6 Expiration Date: 2021-12-22
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Belgium ENG, Canada, China, China APactron, Denmark, France, Germany, Hong Kong S.A.R. China, India, Italy, Japan, Korea, Netherlands, Norway, Poland, Singapore, Spain, SwitzerlandENG, Taiwan, Thailand, UK.
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (medical devices), recall Z-1193-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.